The next decade in Alzheimer's care will likely be defined by AI monitoring of subtle changes in cognitive patterns for early detection, targeted anti-inflammatory and anti-pathology drug cocktails for high-risk individuals, and neuromodulation techniques as a complement to pharmacotherapy. Gayatri Devi's vision mirrors the cancer oncology shift toward mutation-specific, subtype-specific treatment.